Presbia PLC (NASDAQ: LENS) and Digirad Corporation (NASDAQ:DRAD) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership.

Insider and Institutional Ownership

16.5% of Presbia PLC shares are owned by institutional investors. Comparatively, 53.0% of Digirad Corporation shares are owned by institutional investors. 74.7% of Presbia PLC shares are owned by insiders. Comparatively, 11.9% of Digirad Corporation shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Profitability

This table compares Presbia PLC and Digirad Corporation’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Presbia PLC N/A -150.69% -124.10%
Digirad Corporation -9.93% 9.82% 6.02%

Volatility & Risk

Presbia PLC has a beta of 0.2, suggesting that its stock price is 80% less volatile than the S&P 500. Comparatively, Digirad Corporation has a beta of 1.85, suggesting that its stock price is 85% more volatile than the S&P 500.

Valuation and Earnings

This table compares Presbia PLC and Digirad Corporation’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio NetIncome Earnings Per Share Price/Earnings Ratio
Presbia PLC $10,000.00 6,163.20 -$15.75 million ($1.20) -3.00
Digirad Corporation $125.47 million 0.40 $14.30 million ($0.58) -4.31

Digirad Corporation has higher revenue and earnings than Presbia PLC. Digirad Corporation is trading at a lower price-to-earnings ratio than Presbia PLC, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings and target prices for Presbia PLC and Digirad Corporation, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Presbia PLC 0 0 3 0 3.00
Digirad Corporation 0 0 1 0 3.00

Presbia PLC currently has a consensus price target of $11.33, indicating a potential upside of 214.81%. Digirad Corporation has a consensus price target of $6.00, indicating a potential upside of 140.00%. Given Presbia PLC’s higher probable upside, analysts plainly believe Presbia PLC is more favorable than Digirad Corporation.

Dividends

Digirad Corporation pays an annual dividend of $0.22 per share and has a dividend yield of 8.8%. Presbia PLC does not pay a dividend. Digirad Corporation pays out -37.9% of its earnings in the form of a dividend.

Summary

Digirad Corporation beats Presbia PLC on 9 of the 14 factors compared between the two stocks.

Presbia PLC Company Profile

Presbia PLC is an ophthalmic device company. The Company develops and markets an optical lens implant for treating presbyopia, the age-related loss of the ability to focus on near objects. The Company’s segment is the restoration of clear vision caused by presbyopia. The Company provides the refractive lens for patient surgeries and accessories for procedures performed exclusively outside the United States. The Company’s lens, referred to as the microlens, is a miniature lens designed to be surgically implanted in a patient’s eye to improve that patient’s ability to see objects at close distances. The microlens is a disc shaped lens that has a refractive zone in the periphery designed to improve near vision problems associated with presbyopia and a central zone that is designed to improve distance vision. The Company’s solution is a standalone solution for plano presbyopes, or those individuals suffering from presbyopia but do not have any other visual disorders.

Digirad Corporation Company Profile

Digirad Corporation provides healthcare solutions. The Company’s segments include Diagnostic Services, Mobile Healthcare, Diagnostic Imaging and Medical Device Sales and Services. Through Diagnostic Services, the Company offers an imaging services program as an alternative to purchasing equipment or outsourcing the procedures to another physician or imaging center. Through Mobile Healthcare segment, the Company provides contract sales services and diagnostic imaging services. Through Diagnostic Imaging segment, the Company sells its internally developed solid-state gamma camera imaging systems and camera maintenance contracts. Through Medical Device Sales and Services segment, the Company provides contract sales services, as well as warranty and post-warranty services, under contract with Philips Healthcare within a defined region in the upper Midwest region of the United States.

Receive News & Ratings for Presbia PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Presbia PLC and related companies with MarketBeat.com's FREE daily email newsletter.